These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 30621553)

  • 1. Management of Peripheral Neuropathy Induced by Chemotherapy.
    Fradkin M; Batash R; Elmaleh S; Debi R; Schaffer P; Schaffer M; Asna N
    Curr Med Chem; 2019; 26(25):4698-4708. PubMed ID: 30621553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and treatment of chemotherapy-induced peripheral neuropathy.
    Piccolo J; Kolesar JM
    Am J Health Syst Pharm; 2014 Jan; 71(1):19-25. PubMed ID: 24352178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.
    Hershman DL; Lacchetti C; Dworkin RH; Lavoie Smith EM; Bleeker J; Cavaletti G; Chauhan C; Gavin P; Lavino A; Lustberg MB; Paice J; Schneider B; Smith ML; Smith T; Terstriep S; Wagner-Johnston N; Bak K; Loprinzi CL;
    J Clin Oncol; 2014 Jun; 32(18):1941-67. PubMed ID: 24733808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Chemotherapy-Induced Peripheral Neuropathy: Systematic Review and Recommendations.
    Hou S; Huh B; Kim HK; Kim KH; Abdi S
    Pain Physician; 2018 Nov; 21(6):571-592. PubMed ID: 30508986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy-induced peripheral neuropathy; impact on quality of life].
    Scheel A; Beijers AJ; Mols F; Faber CG; Vreugdenhil G
    Ned Tijdschr Geneeskd; 2014; 158():A7455. PubMed ID: 25315326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain.
    Blanton HL; Brelsfoard J; DeTurk N; Pruitt K; Narasimhan M; Morgan DJ; Guindon J
    Drugs; 2019 Jun; 79(9):969-995. PubMed ID: 31127530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN).
    Hertz DL; Childs DS; Park SB; Faithfull S; Ke Y; Ali NT; McGlown SM; Chan A; Grech LB; Loprinzi CL; Ruddy KJ; Lustberg M
    Cancer Treat Rev; 2021 Sep; 99():102241. PubMed ID: 34174668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the publication of Clinical Guidelines for the Management of Chemotherapy-Induced Peripheral Neuropathy on the Administration Preferences of Oncology Specialists: Japanese Association of Supportive Care in Cancer.
    Hirayama Y; Yoshida Y; Mori M; Tamura K
    Jpn J Clin Oncol; 2020 Aug; 50(8):897-902. PubMed ID: 32424420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives.
    Ewertz M; Qvortrup C; Eckhoff L
    Acta Oncol; 2015 May; 54(5):587-91. PubMed ID: 25751757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management options for established chemotherapy-induced peripheral neuropathy.
    Pachman DR; Watson JC; Lustberg MB; Wagner-Johnston ND; Chan A; Broadfield L; Cheung YT; Steer C; Storey DJ; Chandwani KD; Paice J; Jean-Pierre P; Oh J; Kamath J; Fallon M; Strik H; Koeppen S; Loprinzi CL
    Support Care Cancer; 2014 Aug; 22(8):2281-95. PubMed ID: 24879391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-induced peripheral neuropathy and rehabilitation: A review.
    Zhang S
    Semin Oncol; 2021 Jun; 48(3):193-207. PubMed ID: 34607709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melittin, a honeybee venom derived peptide for the treatment of chemotherapy-induced peripheral neuropathy.
    Tender T; Rahangdale RR; Balireddy S; Nampoothiri M; Sharma KK; Raghu Chandrashekar H
    Med Oncol; 2021 Apr; 38(5):52. PubMed ID: 33796975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention, diagnosis and management of chemotherapy-induced peripheral neuropathy: a cross-sectional study of French oncologists' professional practices.
    Selvy M; Pereira B; Kerckhove N; Busserolles J; Farsi F; Guastella V; Merle P; Pezet D; Balayssac D
    Support Care Cancer; 2021 Jul; 29(7):4033-4043. PubMed ID: 33403401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic strategies for cancer treatment related peripheral neuropathies.
    Pachman DR; Watson JC; Loprinzi CL
    Curr Treat Options Oncol; 2014 Dec; 15(4):567-80. PubMed ID: 25119581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin-norepinephrine reuptake inhibitors for the management of chemotherapy-induced peripheral neuropathy.
    Aziz MT; Good BL; Lowe DK
    Ann Pharmacother; 2014 May; 48(5):626-32. PubMed ID: 24577146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
    Kuriyama A; Endo K
    Support Care Cancer; 2018 Apr; 26(4):1051-1059. PubMed ID: 29280005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
    Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
    Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-induced peripheral neuropathy: assessment of oncology nurses' knowledge and practice.
    Binner M; Ross D; Browner I
    Oncol Nurs Forum; 2011 Jul; 38(4):448-54. PubMed ID: 21708535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review.
    Schloss J; Colosimo M; Vitetta L
    Crit Rev Food Sci Nutr; 2017 Apr; 57(6):1107-1118. PubMed ID: 25849070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analgesic efficacy of pregabalin administered according to either a prevention protocol or an intervention protocol in rats with cisplatin-induced peripheral neuropathy.
    Han FY; Kuo A; Nicholson JR; Corradinni L; Smith MT
    Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):1067-1075. PubMed ID: 29781509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.